Thursday, November 21, 2024
Subscribe American Journal of Medicine Free Newsletter
CardiologyCyanosis

Cyanosis

cyanosisDescriptions of cyanopathia or Morbus caeruleus (cyanosis) have populated medical literature since the time of Hippocrates, although the actual pathophysiology behind its development eluded physicians until the advent of objective anatomy and physiology. Morgagni, “accurate anatomist,” philosopher, and one of the fathers of contemporary medicine, is often credited with having first described cyanosis (in association with stasis due to pulmonic stenosis [1761]),(1) however, it was actually deSenac, personal physician to King Louis XV (and the first to elucidate the relationship between atrial fibrillation and mitral stenosis), who first described the pathophysiology of cyanosis (albeit not entirely correctly!) in 1749.(2) It was not until over 2 centuries later, however, that Christen Lundsgaard actually quantified the amount of deoxygenated hemoglobin that was required to produce that bluish discoloration that produces the clinical finding of cyanosis.(2)

Features of Cyanosis
Cyanosis is an abnormal bluish discoloration of the skin and mucous membranes; it is caused by high levels of deoxygenated (reduced) hemoglobin (or its derivatives) circulating within the superficial dermal capillaries and subpapillary venous plexus (not, as commonly taught, the deeper arteries and veins).(1) Hypoxemia, not to be confused with hypoxia (which reflects tissue oxygenation), is the deficient oxygenation of blood that leads to cyanosis.(3)

Whether or not cyanosis is apparent to the human eye depends on dermal thickness, cutaneous pigmentation, and state of the cutaneous capillaries.(4) In light of this, cyanosis is best appreciated in areas of the body where the overlying epidermis is thin and the blood vessel supply abundant, such as the lips, malar prominences (nose and cheeks), ears, and oral mucous membranes (buccal, sublingual); it is better appreciated in fluorescent lighting.(1)

To read this article in its entirety, please visit our website.

— Sarah M. McMullen, MD, Ward Patrick, MD

This article originally appeared in the March 2013 issue of The American Journal of Medicine.

Previous article
Next article

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...